NEUCA Future Growth
Future criteria checks 3/6
NEUCA is forecast to grow earnings and revenue by 25.6% and 4.4% per annum respectively.
Key information
25.6%
Earnings growth rate
n/a
EPS growth rate
Healthcare earnings growth | 27.5% |
Revenue growth rate | 4.4% |
Future return on equity | 18.8% |
Analyst coverage | Low |
Last updated | 19 Nov 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 14,309 | 298 | 282 | 465 | 2 |
12/31/2025 | 13,682 | 247 | 241 | 409 | 2 |
12/31/2024 | 12,967 | 194 | 278 | 404 | 2 |
9/30/2024 | 12,343 | 161 | 94 | 189 | N/A |
6/30/2024 | 12,125 | 165 | 220 | 322 | N/A |
3/31/2024 | 11,973 | 155 | 197 | 291 | N/A |
12/31/2023 | 11,813 | 146 | 194 | 288 | N/A |
9/30/2023 | 11,813 | 128 | 185 | 267 | N/A |
6/30/2023 | 11,654 | 108 | 234 | 319 | N/A |
3/31/2023 | 11,418 | 125 | 260 | 346 | N/A |
12/31/2022 | 11,232 | 137 | 254 | 336 | N/A |
9/30/2022 | 10,962 | 148 | 258 | 334 | N/A |
6/30/2022 | 10,705 | 163 | 239 | 298 | N/A |
3/31/2022 | 10,381 | 161 | 285 | 340 | N/A |
12/31/2021 | 9,864 | 151 | 247 | 300 | N/A |
9/30/2021 | 9,575 | 144 | 244 | 304 | N/A |
6/30/2021 | 9,329 | 149 | 427 | 495 | N/A |
3/31/2021 | 8,907 | 142 | 242 | 317 | N/A |
12/31/2020 | 9,245 | 142 | 240 | 325 | N/A |
9/30/2020 | 8,996 | 148 | 294 | 381 | N/A |
6/30/2020 | 8,695 | 131 | -42 | 62 | N/A |
3/31/2020 | 8,772 | 130 | 64 | 180 | N/A |
12/31/2019 | 8,272 | 117 | 81 | 202 | N/A |
9/30/2019 | 8,079 | 116 | 96 | 218 | N/A |
6/30/2019 | 7,941 | 113 | 281 | 388 | N/A |
3/31/2019 | 7,731 | 100 | 50 | 152 | N/A |
12/31/2018 | 7,753 | 95 | 31 | 141 | N/A |
9/30/2018 | 7,700 | 103 | 26 | 134 | N/A |
6/30/2018 | 7,643 | 99 | N/A | -19 | N/A |
3/31/2018 | 7,645 | 95 | N/A | 142 | N/A |
12/31/2017 | 7,485 | 94 | N/A | 122 | N/A |
9/30/2017 | 7,433 | 91 | N/A | 132 | N/A |
6/30/2017 | 7,321 | 97 | N/A | 148 | N/A |
3/31/2017 | 7,217 | 107 | N/A | 131 | N/A |
12/31/2016 | 7,077 | 112 | N/A | 175 | N/A |
9/30/2016 | 6,946 | 108 | N/A | 146 | N/A |
6/30/2016 | 6,897 | 105 | N/A | 150 | N/A |
3/31/2016 | 6,920 | 105 | N/A | 185 | N/A |
12/31/2015 | 6,946 | 101 | N/A | 180 | N/A |
9/30/2015 | 7,011 | 113 | N/A | 160 | N/A |
6/30/2015 | 7,100 | 100 | N/A | 181 | N/A |
3/31/2015 | 6,957 | 89 | N/A | 228 | N/A |
12/31/2014 | 6,569 | 93 | N/A | 203 | N/A |
9/30/2014 | 6,199 | 72 | N/A | 102 | N/A |
6/30/2014 | 5,897 | 80 | N/A | 77 | N/A |
3/31/2014 | 5,759 | 89 | N/A | 28 | N/A |
12/31/2013 | 5,795 | 85 | N/A | 28 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 7HD's forecast earnings growth (25.6% per year) is above the savings rate (1%).
Earnings vs Market: 7HD's earnings (25.6% per year) are forecast to grow faster than the German market (21% per year).
High Growth Earnings: 7HD's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 7HD's revenue (4.4% per year) is forecast to grow slower than the German market (5.6% per year).
High Growth Revenue: 7HD's revenue (4.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 7HD's Return on Equity is forecast to be low in 3 years time (18.8%).